Concepedia
Statistics
Publications
3
Citations
265
H-Index
Active since
2016
Affiliations
TUM Klinikum(Current)
Heidelberg University
German Cancer Research Center
Technical University of Munich
Praxis für Hämatologie und Onkologie
Johanna Kauschinger is an author at TUM Klinikum specializing in medicine, myelodysplastic syndrome therapy, and apoptosis.
Publications per year
2016–2019
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells
Ulrike Höckendorf, Monica Yabal, Tobias Herold et al. · Cancer Cell · 2016 · 203 citations · Full text
Medicine, Cancer Biology, Oncology +13
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
Stefanie Jilg, Richard Hauch, Johanna Kauschinger et al. · Experimental Hematology and Oncology · 2019 · 40 citations · Full text
Medicine, Hematology, Pharmacotherapy +16
Selective inhibition of BCL-2 is a promising target in patients with high-risk myelodysplastic syndromes and adverse mutational profile
Veronika Reidel, Johanna Kauschinger, Richard Hauch et al. · Oncotarget · 2018 · 22 citations · Full text
Medicine, Hematology, Oncology +16
1–3 of 3